Jerome Groopman - Net Worth and Insider Trading
Jerome Groopman Net Worth
The estimated net worth of Jerome Groopman is at least $414 dollars as of 2024-05-27. Jerome Groopman is the Director of Traws Pharma Inc and owns about 667 shares of Traws Pharma Inc (TRAW) stock worth over $414. Details can be seen in Jerome Groopman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jerome Groopman has not made any transactions after 2020-05-19 and currently still holds the listed stock(s).
Transaction Summary of Jerome Groopman
Jerome Groopman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jerome Groopman owns 1 companies in total, including Traws Pharma Inc (TRAW) .
Click here to see the complete history of Jerome Groopman’s form 4 insider trades.
Insider Ownership Summary of Jerome Groopman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TRAW | Traws Pharma Inc | 2020-05-19 | director |
Jerome Groopman Latest Holdings Summary
Jerome Groopman currently owns a total of 1 stock. Jerome Groopman owns 667 shares of Traws Pharma Inc (TRAW) as of May 19, 2020, with a value of $414.
Latest Holdings of Jerome Groopman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TRAW | Traws Pharma Inc | 2020-05-19 | 667 | 0.62 | 414 |
Holding Weightings of Jerome Groopman
Jerome Groopman Form 4 Trading Tracker
According to the SEC Form 4 filings, Jerome Groopman has made a total of 1 transactions in Traws Pharma Inc (TRAW) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Traws Pharma Inc is the acquisition of 667 shares on May 19, 2020, which cost Jerome Groopman around $3,600.
Insider Trading History of Jerome Groopman
- 1
Jerome Groopman Trading Performance
GuruFocus tracks the stock performance after each of Jerome Groopman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jerome Groopman is 176.85%. GuruFocus also compares Jerome Groopman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jerome Groopman within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jerome Groopman's insider trading performs compared to the benchmark.
Performance of Jerome Groopman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 60.05 | | | | | |
| Relative Return to S&P 500(%) | 54.07 | | | | | |
Jerome Groopman Ownership Network
Jerome Groopman Owned Company Details
What does Traws Pharma Inc do?
Who are the key executives at Traws Pharma Inc?
Jerome Groopman is the director of Traws Pharma Inc. Other key executives at Traws Pharma Inc include CHIEF MEDICAL OFFICER Victor M Moyo , VP Corp Dev & Gen Counsel Abraham N. Oler , and Chief Medical Officer Steven M Fruchtman .
Traws Pharma Inc (TRAW) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Traws Pharma Inc (TRAW) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Traws Pharma Inc (TRAW) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Traws Pharma Inc (TRAW)'s detailed insider trading history can be found in Insider Trading Tracker table.
Traws Pharma Inc Insider Transactions
Jerome Groopman Mailing Address
Above is the net worth, insider trading, and ownership report for Jerome Groopman. You might contact Jerome Groopman via mailing address: C/o Genta Inc, Two Connell Dr, Berkeley Heights Nj 07922.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
